In a 13D filed on Jan. 21 targeting Garrison Capital (GARS), corporate activist Joseph Stilwell notes that he has taken an "activist position" in 68 publicly-traded companies since 2000. In his most recent 13D, Stilwell Value, LLC disclosed a 5% stake in Garrison, a...
Activist Cannell Capital raised its stake in Lee Enterprises (LEE) to 7.37%. The hedge fund filed a 13D/A on July 30 disclosing a 1.7 million additional share purchase of the newspaper publisher. Cannell is now LEE's largest shareholder. Lee Enterprises owns 49...
Baupost Group activist filings are rare events. Seth Klarman, the renowned value investor who heads Baupost, prefers to take passive stakes in companies. Since 2006, Baupost has filed 352 passive 13G filings, and made only 25 activist 13D filings, according to data from WhaleWisdom.com.
A Mellanox (MLNX) insider bought $2.2 million of the Israeli chip designer as fears China will block a proposed merger with Nvidia Corp (NVDA) pushed the price of MLNX well below the buyout price. Stephen Sanghi, a director of Sunnyvale-based Mellanox since February...
Cloning Carl Icahn is a good idea. Now I'm of course not talking about a laboratory experiment whereby we create an army of little corporate activists that will grow into so many billionaires. Rather, I'm referring to following the renowned...
Activist hedge fund Glenview Capital filed a 13D on Bausch Health (BHC) after market hours Monday. The $13.3B fund, managed by Larry Robbins, disclosed a 5.9% stake in the pharmaceutical company. Bausch Health is now Glenview's #3 portfolio position. BHC shares closed at $18.79...
Paul Singer’s Elliott Management is the largest and arguably the most successful activist hedge fund. So when Singer first buys a stake in a stock, that company’s management shudders, and the share price jumps. Singer’s 13D filing usually means higher prices in the target stock in the...
On May 6, Arconic Inc.'s (ARNC) insiders disclosed the purchase of $1.6 million of stock as the aluminum-parts maker announced additional share buybacks and clarified plans for a spinoff. Chairman and CEO John Plant bought 50,000 shares of ARNC at $22.14. Since March...
Engine Capital filed a 13D targeting PDL BioPharm (PDLI) on Wednesday morning, disclosing a 5.28% stake in the Nevada-based healthcare stock. Engine also disclosed it sent a letter to PDLI's board saying the fund "invested in PDLI because of the significant intrinsic value attributable to...
Macerich insiders have bought a record $2.8 million of the retail mall developer's stock over the last two months as Macerich (MAC) shares hit seven year lows. A great story needs a great title. And what could be better than "Retail Apocalypse" to capture...